Romainville, France

Taoues Temal-Laïb

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Onco3r Therapeutics Bv. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taoues Temal-Laïb. Retrieved from https://idiyas.com/inventor/taoues-temal-laib-2ig478te

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taoues Temal-Laïb: Inventor in Pharmaceutical Research

Introduction

Taoues Temal-Laïb is an inventor based in Romainville, France. His patent work concerns compounds and pharmaceutical compositions intended for the prevention and treatment of a range of diseases.

Latest Patents

Temal-Laïb is associated with 1 patent, titled “Compounds and Pharmaceutical Compositions Thereof for the Treatment of Diseases.” The invention describes compounds defined by Formula I, methods for producing them, pharmaceutical compositions containing them, and methods of treatment using them. The disclosed applications include inflammatory, autoinflammatory, autoimmune, proliferative, and fibrotic diseases; transplantation rejection; conditions affecting cartilage or bone turnover; and diseases associated with elevated levels of IL-6, TNFα, interferons, IL-12, or IL-23. The patent also identifies potential applications in respiratory, endocrine, metabolic, cardiovascular, and dermatological diseases, as well as conditions associated with abnormal angiogenesis.

Career Highlights

Temal-Laïb has been associated with Onco3r Therapeutics BV and Coultreon Biopharma BV. His patent reflects work in pharmaceutical research and the development of potential therapeutic compounds.

Collaborations

His association with Onco3r Therapeutics BV and Coultreon Biopharma BV connects his professional background with companies working in the biotechnology and biopharmaceutical sectors.

Conclusion

Taoues Temal-Laïb’s patent focuses on compounds and treatment approaches with potential relevance across a broad range of diseases, highlighting his contribution to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…